scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

News
2024
2023
Archive
Search news articles

May 6, 2020

Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams’ Role Expanded to Chairman and CEO
May 6, 2020

Rachael Alford, PhD Joins RallyBio to Lead CMC Operations
April 30, 2020

Pear Therapeutics to Release Pear-004 to Help People Living with Schizophrenia During the COVID-19 Crisis
April 8, 2020

Precision NanoSystems Appoints Dr. Andrew Geall as Chief Scientific Officer
April 7, 2020

Vor Biopharma Appoints Dr. Robert Pietrusko as Chief Regulatory and Quality Officer
March 26, 2020

Pear Therapeutics Obtains FDA Authorization for Somryst™, a Prescription Digital Therapeutic for the Treatment of Adults With Chronic Insomnia
March 26, 2020

Precision NanoSystems Announces Partnership with Fujifilm for the Development and GMP Manufacturing of Nanoparticle Based Therapeutics
March 18, 2020

IDEAYA and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Binimetinib in Solid Tumors Harboring GNAQ or GNA11 Hotspot Mutations
March 18, 2020

IDEAYA Biosciences Announces IDE196 Monotherapy Phase 2 Does Selection and Clinical Program Update
March 16, 2020

Homology Medicines Announces Peer-Reviewed Publication of HMI-102 Investigational Gene Therapy Demonstrating Restoration of Normal Metabolic Pathway in PKU Disease Model